Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: Results from the CCG 945 experience

Journal of Neuro-Oncology

Volumn 83, Issue 1, 2007, Pages 1-8

  Hyder, Douglas J ^a   Sung, Lillian ^b   Pollack, Ian F ^c   Gilles, Floyd H ^d   Yates, Allen J ^e   Davis, Richard L ^f   Boyett, James M ^g   Finlay, Jonathan L ^d  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Anaplastic mixed glioma; Anaplastic mixed Oligoastrocytoma; Anaplastic Oligodendroglioma; Brain tumor; Children 0 18; Mixed glioma; Mixed oligoastrocytoma; Pediatric

Indexed keywords

CISPLATIN; CYTARABINE; DACARBAZINE; HYDROXYUREA; LOMUSTINE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROSURGERY; OLIGODENDROGLIOMA; OVERALL SURVIVAL; RELIABILITY; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG THERAPY; FEMALE; GLIOMA; HUMANS; INFANT; MALE; NEUROSURGICAL PROCEDURES; OLIGODENDROGLIOMA; RADIOTHERAPY; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34247547957     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9299-6     Document Type: Article

References (29)

1. Childhood Brain Tumor Consortium (1988) A study of childhood brain tumors based on surgical biopsies from ten North American institutions: sample description. Childhood brain Tumor Consortium. J Neuro-oncol 6:9-23
2. Central et al (eds) (2002) CBTRUS, Statistical Report: Primary brain tumors in the United States 1995-1999. Chicago, p 40
3. Kleihues P, Cavenee WL (1997) Pathology and Genetics Tumours of the Central Nervous System. International Agency for Research on Cancer, Lyon
4. Kraus JA et al (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95
5. Maintz D, et al (1997) Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 56:1098-1104
6. Smith JS et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645
7. Gilles FH et al (1994) Histologic feature reliability in childhood neural tumors. Childhood Brain Tumor Consortium. J Neuropathol Exp Neurol 53:559-571
8. Pollack IF et al (2003) The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience. Neuro-oncol 5:197-207
9. Schwartz D, Lellouch J (1967) Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20:637-648
10. Tsiatis A (1990) Analysis and interpretation of trial results: Intent-to-treat analysis. J Acquir Immune Defic Syndr 3:S120-S123
11. Finlay JL et al (1994) Pre-irradiation chemotherapy in children with high-grade astrocytoma: Tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945. J Neurooncol 21:255-265
12. Wisoff JH et al (1998) Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: A report of the Children's Cancer Group trial no. CCG-945. J Neurosurg 89:52-59
13. Allen JC et al (1998) Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: A pilot study of CCG-945. Children's Cancer Group. J Neurosurg 88:215-220
14. Finlay JL, Wisoff JH (1999) The impact of extent of resection in the management of malignant gliomas of childhood. Childs Nerv Syst 15:786-788
15. Pollack IF et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346:420-427
16. Bertolone SJ et al (2003) Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: A Children's Cancer Group report. J Neurooncol 63:49-54
17. Fouladi M et al (2003) Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer 98:1243-1252
18. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system, 2nd edn. Springer, Berlin, pp 11-16
19. Pollack IF et al (2002) Impact of proliferation index on outcome in childhood malignant gliomas: Results in a multi-institutional cohort. Neurosurgery 50:1238-1244, discussion 1244-1245
20. Jaccard P (1901) Distribution de la flore alpine dans le Bassin des Dranses et dans quelques regions voisines. Bull Soc Vaud Sci Nat 37:241-2729
21. Dice LR (1945) Measures of the amount of ecological association between species. Ecol 26:297-302
22. Hillenmeyer M http://www.stanford.edu/∼aureenh/quals/html/ml/ node68.html
23. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biomet 33:159-174
24. Demetris AJ et al (1991) Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. Hepatol 14:751-755
25. Pollack IF et al (1995) Low-grade gliomas of the cerebral hemispheres in children: An analysis of 71 cases. J Neurosurg 82:536-547
26. Pollack IF et al (2003) Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: Results from the CCG-945 cohort. Pediatr Neurosurg 39:114-121
27. Burton EC, Prados MD (2000) Malignant gliomas. Curr Treat Options Oncol 1:459-468
28. Engelhard HH, Stelea A, Mundt A (2003) Oligodendroglioma and anaplastic oligodendroglioma: Clinical features, treatment, and prognosis. Surg Neurol 60:443-456
29. Buckner JC et al (2003) Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities. J Clin Oncol 21:251-255